How UNC Health saved $5.4M on staff turnover costs

The latest stories trending on MedCity News.

Editor's Pick

Top Story How UNC Health Saved Over $5M On Annual Nurse Turnover Costs UNC Health published a study showing that Laudio's automation software saved the health system $5.4 million in annual nurse turnover costs. The startup's technology automates administrative tasks for frontline nurse managers — such as patient rounding, schedule making, and quality and safety checks. Sponsored Content The 2023 Benefit Consultant Index Report Presented by Quantum Health and MedCity News The role of the benefits consultant is more demanding than ever before. In this new survey, benefits consultants shared their perspectives on benefit consolidation, integration, and the future of healthcare navigation. They also shared insights on how they're bridging plans, providers, and customized therapies to create more streamlined patient journeys. Read the full survey results here Ask The Investor Limited engagement, max of 5 people per table, will get breakfast and in-person time with investors. Don't miss this exciting and exclusive opportunity to get all your burning questions answered when you join us on October 26th at INVEST Digital Health at Pegasus Park in Dallas. Sign Up Now

Featured News

These 10 Trends Are Affecting The Healthcare Economy The Most Healthcare-focused market research firm Trilliant Health published a report detailing the 10 most significant economic trends affecting U.S. healthcare stakeholders in 2023. Some of the main ideas covered in the report included Americans' worsening physical and mental health, the industry's shift away from traditional care pathways, and the way patients' decision making is becoming increasingly driven by consumerism. Where Do DTC Providers and Payers Stand When It Comes to Telehealth? A new J.D. Power report found that CVS ranks highest for telehealth satisfaction among direct-to-consumer companies, while UnitedHealthcare ranks highest among payers. Novartis Kidney Disease Drug Hits First Goal of Study; 2024 FDA Filing Planned Novartis's iptacopan met the first of two main goals in its pivotal study in immunoglobulin A nephropathy, and the pharma giant plans to seek accelerated FDA approval next year. The drug could challenge two available therapies for the rare kidney disorder. Weight Loss Drugs Will Have Impact Far Beyond Just On Drugmakers A new PitchBook report listed several predictions for digital health companies in regards to weight loss drugs, including the potential for new weight loss startups and possible challenges for existing nutrition companies. Invitae's First of Its Kind Cancer Test Receives FDA Marketing Authorization The FDA awarded marketing authorization for a new Invitae test that uses next-generation sequencing to assess multiple genes to identify variants indicating a person's predisposition for certain cancers. The regulatory action creates a new regulatory classification making Invitae's test the predicate device for future cancer tests.

Resources

MedCity Moves Podcast: Recent Hires, Layoffs & an Interview with Chris Allen, CFO at Keck Medicine of USC For September's guest interview, we were joined by Chris Allen, who recently became CFO at Keck Medicine of USC. Some of his recent past roles include CFO of Adventist Health and senior director of budget and decision support at UC Irvine Health. Listen Now

MedCity News • PO Box 901 • New York, NY unsubscribe